お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、薬用でんぷんの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に薬用でんぷん市場を分類しています。
本レポートでは世界の薬用でんぷん市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Tereos、Cargill、Roquette、Visco Starch、Colorcon、Agrana、Paramesu Biotech、Shandong Liaocheng E Hua Pharmaceutical、SPAC Starch Products (India) Limited、Sanstar Biopolymers Ltd、Ingredion、Shandong Liujia、Universal Starch-Chem Allied Ltd、Hunan Er-Kang Pharmaceutical、Jiangxi Yipusheng Pharmaceutical、Shanxi Mr G Pharmaceutical、Shivangan Food & Pharma、Splenor Starch LLP、Weifang Shengtai Medicine、Taishan Jinantang、Anhui Sunhere Pharmaceutical Excipients

レポートは薬用でんぷんの主要生産者を調査し、主要地域や国の消費状況も提供します。薬用でんぷんの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Corn Starch
    Potato Starch
    Other

用途別の市場セグメント：
    Tablets
    Capsule
    Granular Formulation
    Other

本レポートの詳細内容
本レポートは、世界の薬用でんぷん市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて薬用でんぷん市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の薬用でんぷん生産量、成長率、市場シェアを調査している。

二. 消費面では、薬用でんぷんの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの薬用でんぷん売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の薬用でんぷん市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本薬用でんぷんのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：薬用でんぷんのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 薬用でんぷんの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける薬用でんぷんの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章薬用でんぷんメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：薬用でんぷんの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：薬用でんぷんの主要メーカーの概要を提供し、製品の説明と仕様、薬用でんぷんの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：薬用でんぷんの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Pharmaceutical Starch market is projected to grow from US$ 1488 million in 2025 to US$ 2040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.
Starches are typically derived from corn or potato. Starches are used in the pharmaceutical industry for a wide variety of reasons, such as an excipient, a tablet and capsule diluent, a tablet and capsule disintegrant, a glidant, or as binder. Disintegrants enable tablets and capsules to break down into smaller fragments (dissolve) so that the drug can be released for absorption. Starches also absorb water rapidly, allowing tablets to disintegrate appropriately.
There are many players in the market, Tereos, Cargill, Roquette, Visco Starch, Colorcon and others are playing important roles in Pharmaceutical Starch industry. Top 5 players occupied about 15.29% market revenue share, The market is not concentrated for now and is still to be dispersed. Pharmaceutical starch is widely used as a binding and disintegrating agent for tablets, pills and granules, also used as filler for capsules. By application, Tablets is the largest consumer group, with consumption market share of 57%. Then followed by the Capsule which account for 22.3%. There are many different types of Pharmaceutical Starch. Based on the major consumption types, the market can be segmented into: Corn Starch, Potato Starch and Others. Corn Starch is the most commonly used types and took 90% market share, while Potato Starch took 6.8% market share and Other types took 2.5%. As for consumption market, revenue of Pharmaceutical Starch in United States took about 30.1% market share, which is the biggest consumption country in current market pattern. China ranks the second largest consumption country, with market share of 9.7%.
In terms of consumption side, this report focuses on the sales of Pharmaceutical Starch by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Pharmaceutical Starch, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pharmaceutical Starch, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Starch, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Starch sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharmaceutical Starch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharmaceutical Starch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Tereos, Cargill, Roquette, Visco Starch, Colorcon, Agrana, Paramesu Biotech, Shandong Liaocheng E Hua Pharmaceutical, SPAC Starch Products (India) Limited, Sanstar Biopolymers Ltd, etc.

Market Segmentation
By Company
    Tereos
    Cargill
    Roquette
    Visco Starch
    Colorcon
    Agrana
    Paramesu Biotech
    Shandong Liaocheng E Hua Pharmaceutical
    SPAC Starch Products (India) Limited
    Sanstar Biopolymers Ltd
    Ingredion
    Shandong Liujia
    Universal Starch-Chem Allied Ltd
    Hunan Er-Kang Pharmaceutical
    Jiangxi Yipusheng Pharmaceutical
    Shanxi Mr G Pharmaceutical
    Shivangan Food & Pharma
    Splenor Starch LLP
    Weifang Shengtai Medicine
    Taishan Jinantang
    Anhui Sunhere Pharmaceutical Excipients

Segment by Type
    Corn Starch
    Potato Starch
    Other

Segment by Application
    Tablets
    Capsule
    Granular Formulation
    Other

Production by Region
    China
    India
    North America
    Europe

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pharmaceutical Starch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pharmaceutical Starch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Starch sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Pharmaceutical Starch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of Corn Starch
 Table 3. Major Manufacturers of Potato Starch
 Table 4. Major Manufacturers of Other
 Table 5. Global Pharmaceutical Starch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 6. Global Pharmaceutical Starch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 7. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 8. Global Revenue Market Share by Region (2020-2031)
 Table 9. Global Pharmaceutical Starch Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
 Table 10. Global Pharmaceutical Starch Sales by Region (2020-2031) & (MT)
 Table 11. Global Sales Market Share by Region (2020-2031)
 Table 12. Global Pharmaceutical Starch Sales by Manufacturers (2020-2025) & (MT)
 Table 13. Global Pharmaceutical Starch Sales Share by Manufacturers (2020-2025)
 Table 14. Global Pharmaceutical Starch Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical Starch Revenue Market Share by Manufacturers (2020-2025)
 Table 16. Global Key Players of Pharmaceutical Starch, Industry Ranking, 2023 VS 2024 VS 2024
 Table 17. Pharmaceutical Starch Price by Manufacturers (2020-2025) & (USD/MT)
 Table 18. Global Pharmaceutical Starch Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 19. Global Pharmaceutical Starch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Starch as of 2024)
 Table 20. Global Key Manufacturers of Pharmaceutical Starch, Manufacturing Base Distribution and Headquarters
 Table 21. Global Key Manufacturers of Pharmaceutical Starch, Product Offered and Application
 Table 22. Global Key Manufacturers of Pharmaceutical Starch, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pharmaceutical Starch Sales by Type (2020-2025) & (MT)
 Table 25. Global Pharmaceutical Starch Sales by Type (2026-2031) & (MT)
 Table 26. Global Sales Share by Type (2020-2031)
 Table 27. Global Pharmaceutical Starch Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical Starch Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Revenue Share by Type (2020-2031)
 Table 30. Pharmaceutical Starch Price by Type (2020-2025) & (USD/MT)
 Table 31. Global Pharmaceutical Starch Price Forecast by Type (2026-2031) & (USD/MT)
 Table 32. Global Pharmaceutical Starch Sales by Application (2020-2025) & (MT)
 Table 33. Global Pharmaceutical Starch Sales by Application (2026-2031) & (MT)
 Table 34. Global Sales Share by Application (2020-2031)
 Table 35. Global Pharmaceutical Starch Revenue by Application (2020-2025) & (US$ Million)
 Table 36. Global Pharmaceutical Starch Revenue by Application (2026-2031) & (US$ Million)
 Table 37. Global Revenue Share by Application (2020-2031)
 Table 38. Pharmaceutical Starch Price by Application (2020-2025) & (USD/MT)
 Table 39. Global Pharmaceutical Starch Price Forecast by Application (2026-2031) & (USD/MT)
 Table 40. US & Canada Sales by Type (2020-2031) & (MT)
 Table 41. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 42. US & Canada Sales by Application (2020-2031) & (MT)
 Table 43. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 44. US & Canada Pharmaceutical Starch Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 45. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 46. US & Canada Sales by Country (2020-2031) & (MT)
 Table 47. Europe Sales by Type (2020-2031) & (MT)
 Table 48. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 49. Europe Sales by Application (2020-2031) & (MT)
 Table 50. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 51. Europe Pharmaceutical Starch Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 52. Europe Sales by Country (2020-2031) & (MT)
 Table 53. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 54. China Sales by Type (2020-2031) & (MT)
 Table 55. China Revenue by Type (2020-2031) & (US$ Million)
 Table 56. China Sales by Application (2020-2031) & (MT)
 Table 57. China Revenue by Application (2020-2031) & (US$ Million)
 Table 58. Asia Sales by Type (2020-2031) & (MT)
 Table 59. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 60. Asia Sales by Application (2020-2031) & (MT)
 Table 61. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 62. Asia Pharmaceutical Starch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 63. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 64. Asia Sales by Region (2020-2031) & (MT)
 Table 65. Middle East, Africa and Latin America Sales by Type (2020-2031) & (MT)
 Table 66. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 67. Middle East, Africa and Latin America Sales by Application (2020-2031) & (MT)
 Table 68. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 69. Middle East, Africa and Latin America Pharmaceutical Starch Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 70. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 71. Middle East, Africa and Latin America Sales by Country (2020-2031) & (MT)
 Table 72. Tereos Company Information
 Table 73. Tereos Description and Major Businesses
 Table 74. Tereos Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 75. Tereos Product Model Numbers, Pictures, Descriptions and Specifications
 Table 76. Tereos Recent Developments
 Table 77. Cargill Company Information
 Table 78. Cargill Description and Major Businesses
 Table 79. Cargill Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 80. Cargill Product Model Numbers, Pictures, Descriptions and Specifications
 Table 81. Cargill Recent Developments
 Table 82. Roquette Company Information
 Table 83. Roquette Description and Major Businesses
 Table 84. Roquette Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 85. Roquette Product Model Numbers, Pictures, Descriptions and Specifications
 Table 86. Roquette Recent Developments
 Table 87. Visco Starch Company Information
 Table 88. Visco Starch Description and Major Businesses
 Table 89. Visco Starch Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 90. Visco Starch Product Model Numbers, Pictures, Descriptions and Specifications
 Table 91. Visco Starch Recent Developments
 Table 92. Colorcon Company Information
 Table 93. Colorcon Description and Major Businesses
 Table 94. Colorcon Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 95. Colorcon Product Model Numbers, Pictures, Descriptions and Specifications
 Table 96. Colorcon Recent Developments
 Table 97. Agrana Company Information
 Table 98. Agrana Description and Major Businesses
 Table 99. Agrana Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 100. Agrana Product Model Numbers, Pictures, Descriptions and Specifications
 Table 101. Agrana Recent Developments
 Table 102. Paramesu Biotech Company Information
 Table 103. Paramesu Biotech Description and Major Businesses
 Table 104. Paramesu Biotech Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 105. Paramesu Biotech Product Model Numbers, Pictures, Descriptions and Specifications
 Table 106. Paramesu Biotech Recent Developments
 Table 107. Shandong Liaocheng E Hua Pharmaceutical Company Information
 Table 108. Shandong Liaocheng E Hua Pharmaceutical Description and Major Businesses
 Table 109. Shandong Liaocheng E Hua Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 110. Shandong Liaocheng E Hua Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. Shandong Liaocheng E Hua Pharmaceutical Recent Developments
 Table 112. SPAC Starch Products (India) Limited Company Information
 Table 113. SPAC Starch Products (India) Limited Description and Major Businesses
 Table 114. SPAC Starch Products (India) Limited Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 115. SPAC Starch Products (India) Limited Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. SPAC Starch Products (India) Limited Recent Developments
 Table 117. Sanstar Biopolymers Ltd Company Information
 Table 118. Sanstar Biopolymers Ltd Description and Major Businesses
 Table 119. Sanstar Biopolymers Ltd Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 120. Sanstar Biopolymers Ltd Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. Sanstar Biopolymers Ltd Recent Developments
 Table 122. Ingredion Company Information
 Table 123. Ingredion Description and Major Businesses
 Table 124. Ingredion Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 125. Ingredion Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. Ingredion Recent Developments
 Table 127. Shandong Liujia Company Information
 Table 128. Shandong Liujia Description and Major Businesses
 Table 129. Shandong Liujia Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 130. Shandong Liujia Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. Shandong Liujia Recent Developments
 Table 132. Universal Starch-Chem Allied Ltd Company Information
 Table 133. Universal Starch-Chem Allied Ltd Description and Major Businesses
 Table 134. Universal Starch-Chem Allied Ltd Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 135. Universal Starch-Chem Allied Ltd Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. Universal Starch-Chem Allied Ltd Recent Developments
 Table 137. Hunan Er-Kang Pharmaceutical Company Information
 Table 138. Hunan Er-Kang Pharmaceutical Description and Major Businesses
 Table 139. Hunan Er-Kang Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 140. Hunan Er-Kang Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. Hunan Er-Kang Pharmaceutical Recent Developments
 Table 142. Jiangxi Yipusheng Pharmaceutical Company Information
 Table 143. Jiangxi Yipusheng Pharmaceutical Description and Major Businesses
 Table 144. Jiangxi Yipusheng Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 145. Jiangxi Yipusheng Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. Jiangxi Yipusheng Pharmaceutical Recent Developments
 Table 147. Shanxi Mr G Pharmaceutical Company Information
 Table 148. Shanxi Mr G Pharmaceutical Description and Major Businesses
 Table 149. Shanxi Mr G Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 150. Shanxi Mr G Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. Shanxi Mr G Pharmaceutical Recent Developments
 Table 152. Shivangan Food & Pharma Company Information
 Table 153. Shivangan Food & Pharma Description and Major Businesses
 Table 154. Shivangan Food & Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 155. Shivangan Food & Pharma Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Shivangan Food & Pharma Recent Developments
 Table 157. Splenor Starch LLP Company Information
 Table 158. Splenor Starch LLP Description and Major Businesses
 Table 159. Splenor Starch LLP Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 160. Splenor Starch LLP Product Model Numbers, Pictures, Descriptions and Specifications
 Table 161. Splenor Starch LLP Recent Developments
 Table 162. Weifang Shengtai Medicine Company Information
 Table 163. Weifang Shengtai Medicine Description and Major Businesses
 Table 164. Weifang Shengtai Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 165. Weifang Shengtai Medicine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 166. Weifang Shengtai Medicine Recent Developments
 Table 167. Taishan Jinantang Company Information
 Table 168. Taishan Jinantang Description and Major Businesses
 Table 169. Taishan Jinantang Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 170. Taishan Jinantang Product Model Numbers, Pictures, Descriptions and Specifications
 Table 171. Taishan Jinantang Recent Developments
 Table 172. Anhui Sunhere Pharmaceutical Excipients Company Information
 Table 173. Anhui Sunhere Pharmaceutical Excipients Description and Major Businesses
 Table 174. Anhui Sunhere Pharmaceutical Excipients Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 175. Anhui Sunhere Pharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
 Table 176. Anhui Sunhere Pharmaceutical Excipients Recent Developments
 Table 177. Key Raw Materials Lists
 Table 178. Raw Materials Key Suppliers Lists
 Table 179. Distributors List
 Table 180. Customers List
 Table 181. Market Trends
 Table 182. Market Drivers
 Table 183. Market Challenges
 Table 184. Market Restraints
 Table 185. Research Programs/Design for This Report
 Table 186. Key Data Information from Secondary Sources
 Table 187. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceutical Starch Product Picture
 Figure 2. Global Pharmaceutical Starch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Pharmaceutical Starch Market Share by Type: 2024 & 2031
 Figure 4. Corn Starch Product Picture
 Figure 5. Potato Starch Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Pharmaceutical Starch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Global Pharmaceutical Starch Market Share by Application: 2024 & 2031
 Figure 9. Tablets
 Figure 10. Capsule
 Figure 11. Granular Formulation
 Figure 12. Other
 Figure 13. Pharmaceutical Starch Report Years Considered
 Figure 14. Global Pharmaceutical Starch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Pharmaceutical Starch Revenue by Region (2020-2031) (US$ Million)
 Figure 17. Global Pharmaceutical Starch Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 18. Global Pharmaceutical Starch Revenue Market Share by Region (2020-2031)
 Figure 19. Global Pharmaceutical Starch Sales (2020-2031) & (MT)
 Figure 20. Global Pharmaceutical Starch Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 21. Global Pharmaceutical Starch Sales Market Share by Region (2020-2031)
 Figure 22. US & Canada Pharmaceutical Starch Sales YoY (2020-2031) & (MT)
 Figure 23. US & Canada Pharmaceutical Starch Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Starch Sales YoY (2020-2031) & (MT)
 Figure 25. Europe Pharmaceutical Starch Revenue YoY (2020-2031) & (US$ Million)
 Figure 26. China Pharmaceutical Starch Sales YoY (2020-2031) & (MT)
 Figure 27. China Pharmaceutical Starch Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Asia (excluding China) Pharmaceutical Starch Sales YoY (2020-2031) & (MT)
 Figure 29. Asia (excluding China) Pharmaceutical Starch Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Middle East, Africa and Latin America Pharmaceutical Starch Sales YoY (2020-2031) & (MT)
 Figure 31. Middle East, Africa and Latin America Pharmaceutical Starch Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Global Pharmaceutical Starch Sales Share by Manufacturers (2024)
 Figure 33. The Pharmaceutical Starch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 34. Global Pharmaceutical Starch Revenue Share by Manufacturers (2024)
 Figure 35. The Top 5 and 10 Largest Manufacturers of Pharmaceutical Starch in the World: Market Share by Pharmaceutical Starch Revenue in 2024
 Figure 36. Global Pharmaceutical Starch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 37. Global Pharmaceutical Starch Sales Market Share by Type (2020-2031)
 Figure 38. Global Pharmaceutical Starch Revenue Market Share by Type (2020-2031)
 Figure 39. Global Pharmaceutical Starch Sales Market Share by Application (2020-2031)
 Figure 40. Global Pharmaceutical Starch Revenue Market Share by Application (2020-2031)
 Figure 41. US & Canada Pharmaceutical Starch Sales Market Share by Type (2020-2031)
 Figure 42. US & Canada Pharmaceutical Starch Revenue Market Share by Type (2020-2031)
 Figure 43. US & Canada Pharmaceutical Starch Sales Market Share by Application (2020-2031)
 Figure 44. US & Canada Pharmaceutical Starch Revenue Market Share by Application (2020-2031)
 Figure 45. US & Canada Pharmaceutical Starch Revenue Share by Country (2020-2031)
 Figure 46. US & Canada Pharmaceutical Starch Sales Share by Country (2020-2031)
 Figure 47. US Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 48. Canada Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 49. Europe Pharmaceutical Starch Sales Market Share by Type (2020-2031)
 Figure 50. Europe Pharmaceutical Starch Revenue Market Share by Type (2020-2031)
 Figure 51. Europe Pharmaceutical Starch Sales Market Share by Application (2020-2031)
 Figure 52. Europe Pharmaceutical Starch Revenue Market Share by Application (2020-2031)
 Figure 53. Europe Pharmaceutical Starch Sales Share by Country (2020-2031)
 Figure 54. Europe Pharmaceutical Starch Revenue Share by Country (2020-2031)
 Figure 55. Germany Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 56. France Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 57. U.K. Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 58. Italy Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 59. Russia Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 60. China Pharmaceutical Starch Sales Market Share by Type (2020-2031)
 Figure 61. China Pharmaceutical Starch Revenue Market Share by Type (2020-2031)
 Figure 62. China Pharmaceutical Starch Sales Market Share by Application (2020-2031)
 Figure 63. China Pharmaceutical Starch Revenue Market Share by Application (2020-2031)
 Figure 64. Asia Pharmaceutical Starch Sales Market Share by Type (2020-2031)
 Figure 65. Asia Pharmaceutical Starch Revenue Market Share by Type (2020-2031)
 Figure 66. Asia Pharmaceutical Starch Sales Market Share by Application (2020-2031)
 Figure 67. Asia Pharmaceutical Starch Revenue Market Share by Application (2020-2031)
 Figure 68. Asia Pharmaceutical Starch Revenue Share by Region (2020-2031)
 Figure 69. Asia Pharmaceutical Starch Sales Share by Region (2020-2031)
 Figure 70. Japan Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 71. South Korea Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 72. China Taiwan Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 73. Southeast Asia Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 74. India Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 75. Australia Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 76. Middle East, Africa and Latin America Pharmaceutical Starch Sales Market Share by Type (2020-2031)
 Figure 77. Middle East, Africa and Latin America Pharmaceutical Starch Revenue Market Share by Type (2020-2031)
 Figure 78. Middle East, Africa and Latin America Pharmaceutical Starch Sales Market Share by Application (2020-2031)
 Figure 79. Middle East, Africa and Latin America Pharmaceutical Starch Revenue Market Share by Application (2020-2031)
 Figure 80. Middle East, Africa and Latin America Pharmaceutical Starch Revenue Share by Country (2020-2031)
 Figure 81. Middle East, Africa and Latin America Pharmaceutical Starch Sales Share by Country (2020-2031)
 Figure 82. Brazil Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 83. Mexico Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 84. Turkey Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 85. Israel Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 86. GCC Countries Pharmaceutical Starch Revenue (2020-2031) & (US$ Million)
 Figure 87. Value Chain
 Figure 88. Pharmaceutical Starch Production Process
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed